1. Home
  2. THFF vs EYPT Comparison

THFF vs EYPT Comparison

Compare THFF & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Corporation Indiana

THFF

First Financial Corporation Indiana

HOLD

Current Price

$63.80

Market Cap

686.6M

Sector

Finance

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$16.10

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
THFF
EYPT
Founded
1984
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
686.6M
1.5B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
THFF
EYPT
Price
$63.80
$16.10
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$60.00
$29.60
AVG Volume (30 Days)
52.3K
1.1M
Earning Date
10-28-2025
11-05-2025
Dividend Yield
3.18%
N/A
EPS Growth
69.68
N/A
EPS
6.25
N/A
Revenue
$250,755,000.00
$42,339,000.00
Revenue This Year
$33.24
N/A
Revenue Next Year
$8.15
N/A
P/E Ratio
$10.26
N/A
Revenue Growth
31.89
N/A
52 Week Low
$42.05
$3.91
52 Week High
$65.00
$19.11

Technical Indicators

Market Signals
Indicator
THFF
EYPT
Relative Strength Index (RSI) 74.06 60.28
Support Level $58.01 $15.97
Resistance Level $65.00 $19.11
Average True Range (ATR) 1.24 0.96
MACD 0.51 0.11
Stochastic Oscillator 90.71 46.36

Price Performance

Historical Comparison
THFF
EYPT

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: